Abstract:Objective: Osteosarcoma (OS) is the most common primary bone malignancy with a high propensity for local invasion and distant metastasis. Flavokawain A and B (FKA and FKB) from kava extract have been reported to have significant anti-tumoral effects on human cancer cells. The consumption of kava-containing beverage has been associated with a low cancer incidence. The objective of this study is to investigate the anti-tumoral effects of flavokawains in OS. In a previous report, mice treated with high-dose FKA did not demonstrate any significant major organ toxicity. MicroRNAs (miRNA), endogenous, non-coding RNA, are associated with cell-cycle regulation, differentiation, proliferation, apoptosis, and migration. There remains a paucity of literature on the effects of flavokawains on the expression of miRNA in OS. As such, we hypothesize that flavokawains will up-regulate tumor-suppressive miRNA in OS cell lines. Methods: Human OS cell lines from American Type Culture Collection (ATCC), patient-derived OS cell lines, human mesenchymal stem cells, human intestinal epithelial cells, and mouse bone marrow cells were cultured. Cell lines were divided into control and treatment groups with increasing doses of FKA or FKB. Cell viability was determined by MTT proliferation assays and cytotoxicity to bone marrow cells was examined by colony formation. Effects of flavokawain on intestinal cells were examined by fluorescent cytotoxicity and flow cytometry. Apoptotic assays were performed following flavokawain treatments. The expression of miRNA after FKA and FKB treatment was examined by qRT-PCR. SCID mice were injected with OS 143B cells in the tibia and treated with either vehicle control or FKA (200 mg/kg) by oral gavage. Results: By flow cytometry, FKB increases apoptosis of OS 143B cells while sparing intestinal FHs 74 intestinal cells. Mouse bone marrow cells treated with FKB showed no significant difference in colony forming units compared to control cells. Exposure of OS cell lines to FKA or FKB resulted in a loss of cell viability in a dose-dependent manner. In all cell lines tested a dose-dependent expression of miRNA was observed after exposure to FKA or FKB. Flavokawain B induced miR-26a while FKA induced miR-26a, miR-34, and miR-203 expression in OS cell lines. Mice bearing 143B xenograft tumors treated with FKA did not exhibit weight loss compared to control animals. Animals treated with FKA sustained less lung metastasis than animals treated with vehicle control. Conclusions: Taken together, the evidence suggests flavokawains up-regulate tumor suppressive miRNAs in OS cells. In vivo experiments suggest that FKA exerts anti-metastatic effects in OS. Given their low toxicity profile, flavokawains may be useful as a chemopreventive strategy for OS and thus warrant further investigations. Citation Format: Wendong Zhang, Jonathan Morris, Sajida Piperdi, Yi Guo, Tao Ji, Rui Yang, Michael Roth, Jonathan Gill, David S. Geller, Richard Gorlick, Kevin Jones, Xiaolin Zi, Bang H. Hoang. Flavokawain A and B from kava extract exhibits low toxicity and up-regulates tumor suppressor miRNAs in human osteosarcoma cells. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2182.

The kava chalcone flavokawain B exerts inhibitory activity and synergizes with BCL-2 inhibition in malignant B-cell lymphoma

Synergistic Lethality Effects of ABT-199 and Apatinib on DLBCL: Antitumor Efficacy and Underlying Mechanisms

Flavokawain B, a Kava Chalcone, Inhibits Growth of Human Osteosarcoma Cells Through G2/M Cell Cycle Arrest and Apoptosis

The In Vitro and In Vivo Anticancer Properties of Chalcone Flavokawain B through Induction of ROS-Mediated Apoptotic and Autophagic Cell Death in Human Melanoma Cells

Apigenin and Abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma in vivo and vitro

Flavokawain B Weakens Gastric Cancer Progression via the TGF-β1/SMAD4 Pathway and Attenuates M2 Macrophage Polarization

Flavokawain B Inhibits the Growth of Acute Lymphoblastic Leukemia Cells Via P53 and Caspase-Dependent Mechanisms

Chalcone flavokawain B induces autophagic-cell death via reactive oxygen species-mediated signaling pathways in human gastric carcinoma and suppresses tumor growth in nude mice

A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models.

Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma

B4 suppresses lymphoma progression by inhibiting fibroblast growth factor binding protein 1 through intrinsic apoptosis

Preclinical Studies of Chiauranib Inhibit Follicular Lymphoma Through VEGFR2/ERK/STAT3 Signaling Pathway

Combinatorial inhibition of focal adhesion kinase and BCL-2 enhances anti-leukemia activity of venetoclax in acute myeloid leukemia.

Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 in AML

A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality with BTK or MDM2-P53 Inhibitor in Diffuse Large B-Cell Lymphoma.

ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway

Flavokawain A, A Kava Chalcone, Inhibits Growth And Invasion Of Human Osteosarcoma Cells By Targeting Skp2

A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway

Abstract 2125: Flavokawain A, a Kava Chalcone, Inhibits Growth and Invasion of Human Osteosarcoma Cells by Targeting Skp2

Abstract 2182: Flavokawain A and B from Kava Extract Exhibits Low Toxicity and Up-Regulates Tumor Suppressor Mirnas in Human Osteosarcoma Cells

Kaempferol Exhibits a Synergistic Effect with Doxorubicin to Inhibit Proliferation, Migration, and Invasion of Liver Cancer